Skip to content

The effect of oral black seed oil on knee osteoarthritis

The effect of oral black seed oil capsule on serum level of Tenascin-C in knee osteoarthritis patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210923052559N1
Enrollment
80
Registered
2022-10-11
Start date
2022-09-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Osteoarthritis, unspecified site

Interventions

Intervention 1: Intervention group: Patients in this group will take two black seed capsules per day (every 12 hours) for 3 months.Each capsule of black seed contains 5.3 mg of thymoquinone, the effec

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Knee osteoarthritis Satisfaction to enter the study

Exclusion criteria

Exclusion criteria: Taking medicine for osteoarthritis of the knee Having an infection or primary inflammatory disease in the knee joint Arthritis caused by crystals Intra-articular tumors Knee joint ligament instability Previous intra-articular fracture Knee joint surgery (arthroscopic or otherwise) in the last 12 months Injection of any intra-articular drug in the last 3 months Existence of simultaneous severe diseases (metabolic diseases and history of stroke in the past)

Design outcomes

Primary

MeasureTime frame
The amount of pain in the knee area. Timepoint: At the beginning of the study (before the start of the intervention) and 1, 2 and 3 months after the start of black seed oil capsules. Method of measurement: WOMAC questionnaire.;Tenascin-C serum level. Timepoint: At the beginning of the study (before the start of intervention) and 3 months after the start of taking black seed oil capsules. Method of measurement: ELISA method using the Tenascin-c kit from Zellbio GmbH company.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMandana Khodashahi

Mashhad University of Medical Sciences

Khodashahim@mums.ac.ir+98 51 3801 2496

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026